Wednesday, February 10, 2010, 9:18pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

3SBio Inc. (SSRX)

At 5:00AM SGT: 10.18 USD   0.00 (0.00%)  
 MORE ON SSRX 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 3SBio Inc. (NasdaqNM:SSRX) Delayed quote dataEdit
Last Trade:10.18 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:10.18
Open:N/A
Bid:9.18 x 200
Ask:1,999.00 x 300
1y Target Est:14.75
Day's Range:N/A - N/A
52wk Range:4.18 - 14.45
Volume:0
Avg Vol (3m):98,919
Market Cap:219.06M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add SSRX to Portfolio   Download Data

 HEADLINES 
•3SBio Gains China Rights to Another Dialysis Drug
at Seeking Alpha (Tue 3:43pm)
•3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia
PR Newswire (Mon, Feb 8)
•3SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010
PR Newswire (Tue, Jan 26)
•2 Stocks Hitting Low Notes
at Motley Fool (Tue, Jan 26)
•AMAG Pharma Guides on Feraheme
Zacks.com (Tue, Jan 12)
•China Biotech Week in Review: New Investments for a New Year
at Seeking Alpha (Sun, Jan 10)
•3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM)
PR Newswire (Fri, Jan 8)
•Prospecting for Stocks: QLT
at Motley Fool (Thu, Dec 17)
•The Wrong Way to Invest in China
at Motley Fool (Fri, Dec 11)
•Build Your Fortune With These Winners
at Motley Fool (Fri, Dec 4)
•Biotech Bargains for Your Portfolio
at Motley Fool (Fri, Nov 27)
•3SBIO INC Earnings Call scheduled for 8:00 am ET today
CCBN (Fri, Nov 13)
•3SBio Inc. Announces Unaudited Third Quarter 2009 Results
PR Newswire (Fri, Nov 13)
More Headlines for SSRX...
 ANALYST 
EPS Est (next year) (Dec-09) :0.56
EPS Est (in 2 years) (Dec-10) :0.65
Avg Rec (current)*:1.5
PEG Ratio:1.50
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
3SBio Inc., a biotechnology company, focuses on the research, development, manufacture, and marketing of biopharmaceutical products primarily in the People’s Republic of China.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices